Adjuvant hormone therapy following primary therapy for endometrial cancer.
Loibl
S
S
Universitätsfrauenklinik, Theodor-Stern-Kai 7, Frankfurt am Main, Germany. loibl@em.uni-frankfurt.de
von Minckwitz
G
G
Kaufmann
M
M
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D016889:Endometrial Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D011372:Progestins / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D011372:Progestins; D013629:Tamoxifen